Karuna Therapeutics, Inc. Increase Decrease In Operating Lease Liability
Karuna Therapeutics, Inc. reported Increase Decrease In Operating Lease Liability of -$1.96 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2024-02-22
- Karuna Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2023-12-31 was -$420.00K.
- Karuna Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2023-09-30 was -$201.00K.
- Karuna Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2023-06-30 was -$769.00K.
- Karuna Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2023-03-31 was -$569.00K.
- Karuna Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2023 was -$1.96M.
- Karuna Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2022 was -$2.17M.
- Karuna Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2021 was -$1.22M.
- Karuna Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2020 was -$574.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$420.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$621.00K derived: sum of 2 quarters · filed 2024-02-22 | -$1.39M derived: sum of 3 quarters · filed 2024-02-22 | -$1.96M 10-K · filed 2024-02-22 |
| 2023-09-30 | -$201.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$970.00K derived: sum of 2 quarters · filed 2023-11-02 | -$1.54M 10-Q · filed 2023-11-02 | -$2.10M derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-06-30 | -$769.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$1.34M 10-Q · filed 2023-08-03 | -$1.90M derived: sum of 3 quarters · filed 2024-02-22 | -$2.45M derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-03-31 | -$569.00K 10-Q · filed 2023-05-04 | -$1.13M derived: sum of 2 quarters · filed 2024-02-22 | -$1.68M derived: sum of 3 quarters · filed 2024-02-22 | -$2.22M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-12-31 | -$558.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$1.11M derived: sum of 2 quarters · filed 2024-02-22 | -$1.65M derived: sum of 3 quarters · filed 2024-02-22 | -$2.17M 10-K · filed 2024-02-22 |
| 2022-09-30 | -$551.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.09M derived: sum of 2 quarters · filed 2023-11-02 | -$1.62M 10-Q · filed 2023-11-02 | -$2.13M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$541.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$1.07M 10-Q · filed 2023-08-03 | -$1.58M derived: sum of 3 quarters · filed 2024-02-22 | -$1.96M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$525.00K 10-Q · filed 2023-05-04 | -$1.04M derived: sum of 2 quarters · filed 2024-02-22 | -$1.42M derived: sum of 3 quarters · filed 2024-02-22 | -$1.54M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$516.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$897.00K derived: sum of 2 quarters · filed 2024-02-22 | -$1.02M derived: sum of 3 quarters · filed 2024-02-22 | -$1.22M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$381.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$501.00K derived: sum of 2 quarters · filed 2022-11-03 | -$706.00K 10-Q · filed 2022-11-03 | -$906.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$325.00K 10-Q · filed 2022-08-08 | -$525.00K derived: sum of 3 quarters · filed 2023-02-23 | |
| 2021-03-31 | -$205.00K 10-Q · filed 2022-05-05 | -$405.00K derived: sum of 2 quarters · filed 2023-02-23 | ||
| 2020-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$574.00K 10-K · filed 2023-02-23 | ||
| 2020-09-30 | -$374.00K 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |